Association between Clinical Manifestations and Candida Carriage in Patients with Oral Sub-Mucous Fibrosis
Clinical Manifestations and Candida Carriage in Patients with Oral Sub-Mucous Fibrosis
DOI:
https://doi.org/10.54393/pjhs.v5i11.2427Keywords:
Oral Sub-Mucous Fibrosis, Infection, Candida Carriage, SalivaAbstract
A chronic, progressive disorder known as oral sub-mucous fibrosis causes the oral mucosa to become inflamed and fibrotic, which limits mouth opening, causes a burning sensation, and reduces salivary flow. Objectives: To assess the relationship between candida carriage in oral sub-mucous fibrosis patients and demographic traits, tobacco use, and clinical parameters such as burning sensation, salivary flow rate, and mouth opening. Methods: A comparative cross-sectional study was conducted from May 2024 to Oct 2024. This study was conducted in Multan Medical and Dental College. The total number of patients was 384 divided into 192 with oral sub-mucous fibrosis and 192 control participants split into groups with and without risk exposure. Clinical characteristics such as mouth opening, salivary flow rate, and burning sensation (measured using a visual analogue scale) were evaluated. Data were analyzed with descriptive, mean, Post Hoc analysis, and Chi‑square tests. Results: Comparing the oral sub-mucous fibrosis positive group (93%) to the negative group (7%), the oral sub-mucous fibrosis group had a considerably greater prevalence of candida carriage. Reduced salivary flow rate (≤0.2 ml/min), restricted mouth opening (≤20 mm), and severe burning sensation (3-5 (Visual Analogue Scale)) were shown to be strongly correlated with candida positivity (p<0.001). A greater prevalence of candida colonization was also seen in patients who used tobacco more frequently (p<0.001). Conclusions: It was concluded that comprehensive treatment methods should include patient education on oral hygiene and quitting smoking, given the major impact that these behaviours play in candida's carriage.
References
Hande AH, Sonone A, Porwar R, Lohe V, Dangore S, Meshram M. Evaluation of Oral Microbial Flora in the Saliva of Patients of Oral Sub-Mucous Fibrosis. Journal of Evolution of Medical and Dental Sciences. 2020; 9(7): 409-12. doi: 10.14260/jemds/2020/93.
Sankari SL and Mahalakshmi K. Oral Candida Carriage among Patients with Oral Potential Malignant Disorders: A Case-Control Study. Pesquisa Brasileira em Odontopediatria e Clínica Integrada. 2019 Oct; 19: e4802. doi: 10.4034/PBOCI.2019.191.86.
Shah KM. Association of Candida Species with Oral Sub-Mucous Fibrosis and Oral Leukoplakia: A Case-Control Study. Annals of Clinical and Laboratory Research. 2018; 6: 248. doi: 10.21767/2386-5180.100248.
Sankari SL, Mahalakshmi K, Kumar VN. A comparative Study of Candida Species Diversity among Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders. BioMed Central Research Notes. 2020 Oct; 13(1): 488. doi: 10.1186/s13104-020-05336-3.
Vikey A and Pusame A. Evaluation of Candida Species in Oral Sub-Mucous Fibrosis and Oral Lichen Planus: A Microbiological Study. Microbiology Research Journal International. 2024 May; 34(5): 29-37. doi: 10.9734/mrji/2024/v34i51444.
Sowmya S and Sangavi R. Prevalence of Oral Sub-Mucous Fibrosis with Other Oral Potentially Malignant Disorders: A Clinical Retrospective Study. Cureus. 2023 Nov; 15(11). doi: 10.7759/cureus.49642.
Redhu A, Suman B, Banu A. Relationship of Clinical Features with Candida Carriage in Oral Sub-Mucous Fibrosis Patients: A Case-control Study. Contemporary Clinical Dentistry. 2021 Oct; 12(4): 359-67. doi: 10.4103/ccd.ccd_296_20.
Niklander SE. Inflammatory Mediators in Oral Cancer: Pathogenic Mechanisms and Diagnostic Potential. Frontiers in Oral Health. 2021 Feb; 2: 642238. doi: 10.3389/froh.2021.642238.
Shaikh AH, Ahmed S, Siddique S, Iqbal N, Hasan SM, Zaidi SJ et al. Oral Sub-Mucous Fibrosis; Study of Cases Reported at Dow International Medical College Hospital in Karachi, Pakistan. The Professional Medical Journal. 2019 Feb; 26(02): 275-81. doi: 10.29309/TPMJ/2019.26.02.3100.
Gupta S and Jawanda MK. Oral Sub-Mucous Fibrosis: An Overview of a Challenging Entity. Indian Journal of Dermatology, Venereology and Leprology. 2021 Oct; 87(6): 768-77. doi: 10.25259/IJDVL_371_20.
Sullivan L. Power and sample size determination [Internet]. 2020. DOI:10.1201/9781003261148-27
Deshkar DS, Gaigawale DA, Rangari DP, Raj DA, Aggarwal DC, Tyagi DG. Assessing the Candida in Healthy Subjects and Subjects with Oral Submucous Fibrosis: A Comparative Clinical Study. International Journal of Life Sciences and Pharmaceutical Research. 2022 July; 12(4): L8-13. doi: 10.22376/ijpbs/lpr.2022.12.4.L8-13.
Sanketh DS, Patil S, Rao RS. Estimating the Frequency of Candida in Oral Squamous Cell Carcinoma Using Calcofluor White Fluorescent Stain. Journal of Investigative and Clinical Dentistry. 2016 Aug; 7(3): 304-7. doi: 10.1111/jicd.12161.
Ok SM, Ho D, Lynd T, Ahn YW, Ju HM, Jeong SH et al. Candida Infection Associated with Salivary Gland—A Narrative Review. Journal of Clinical Medicine. 2020 Dec; 10(1): 97. doi: 10.3390/jcm10010097.
Xin W, Leung KC, Lo EC, Mok MY, Leung MH. Sicca Symptoms, Oral Health Conditions, Salivary Flow and Oral Candida in Sjögren’s Syndrome Patients. International Journal of Environmental Research and Public Health. 2020 May; 17(10) :3625. doi: 10.3390/ijerph17103625.
Hu L, He C, Zhao C, Chen X, Hua H, Yan Z. Characterization of Oral Candidiasis and the Candida Species Profile in Patients with Oral Mucosal Diseases. Microbial Pathogenesis. 2019 Sep; 134: 103575. doi: 10.1016/j.micpath.2019.103575.
Agrawal P, Gupta C, Bhola N, Pawar SS, Sonpal PM, Gattani V, AGRAWAL P, SONPAL PM. A Case of Advanced Oral Submucous Fibrosis Management: Beyond Conventional Approach. Cureus. 2024 Jun 7;16(6).
Edel J, Grinstein-Koren O, Winocur-Arias O, Kaplan I, Schnaiderman-Shapiro A, Buchner A et al. Unexpected Candida Hyphae in Oral Mucosa Lesions—A Clinico-Pathological Study. Antibiotics. 2022 Oct; 11(10): 1386. doi: 10.3390/antibiotics11101386. doi: 10.3390/antibiotics11101386.
She R, Xu P. Mechanism of curcumin in the prevention and treatment of oral submucosal fibrosis and progress in clinical application research. BDJ open. 2024 Oct 25;10(1):82.
Mahdani FY, Subarnbhesaj A, Ayuningtyas NF, Surboyo MD, Bakti RK, Radithia D, Paramananda DB, Indriyani I, Basalamah FF. Salivary Profile in Oral Submucous Fibrosis: A Scoping Review. European Journal of Dentistry. 2024 Aug 5. DOI:10.1055/s-0044-1788711
Redhu A, Suman B, Banu A. Relationship of Clinical Features with Candidal Carriage in Oral Submucous Fibrosis Patients: A Case-control Study. Contemporary Clinical Dentistry. 2021 Oct 1;12(4):359-67. doi: 10.4103/ccd.ccd_296_20
Gupta B, Chandra S, Raj V, Gupta V. Comparison of salivary flow and candidal carriage in patients with oral submucous fibrosis. Journal of Oral and Maxillofacial Pathology. 2015 May 1;19(2):158-63. doi: 10.4103/0973-029X.164526
Deshkar DS, Gaigawale DA, Rangari DP, Raj DA, Aggarwal DC, Tyagi DG. Assessing the Candida in Healthy Subjects and Subjects with Oral Submucous Fibrosis: A Comparative Clinical Study..(2022). Int. J. Life Sci. Pharma Res.;12(4):L8-13. DOI:10.22376/ijpbs/lpr.2022.12.4.L8-13
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments